Welcoming Deborah Mash, Doctor, Scientist and Neuroshaman to the Awake Board

Dr. Deborah C. Mash is a Professor of Neurology (Emerita) and Molecular and Cellular Pharmacology at the University of Miami School of Medicine. With over 25 years of continuous NIH funding from the National Institute on Drug Abuse, Deborah is a leading expert on ibogaine and the discoverer of its active metabolite, noribogaine. She secured FDA approval for the first clinical trial of ibogaine in the U.S. in 1993 and conducted research and clinical development studies at a substance abuse treatment center in St. Kitts from 1996 to 2005. In 2010, Deborah co-founded DemeRx to advance noribogaine’s clinical development and took on leadership of the company in 2017. Dr Mash joined the Awake.net Board of Directors June 16th 2025.

NORIBOGAINE

“By specifically targeting structural neuroplasticity within the brain’s addiction circuitry, DMX-1001 aims to facilitate lasting changes that empower individuals to overcome the challenges of alcohol and drug addiction.”
Deborah Mash, PhD, CEO and Founder, Demerx.com

Dr Mash’s mission to help people overcome addiction is aligned with Awake.net’s FEAT mission to end addiction one ibogaine treatment at a time, and creates a very complementary alignment of interests and opportunities to bring together the scientific and the spiritual in the FEAT program and create a medically-supervised mystery school pathway for individuals wishing to end their addiction and rejoin society with purpose and passion.

Learn more about the FEAT Fund for Entheogenic Addiction Treatment, the FEAT Journey of Rebirth, and the FEAT Care Team.

Recommend0 recommendationsPublished in Awake Daily Dose, Uncategorized

Subscribe to Awake Events & Posts

Related Articles

Mediamakers: Write a Post

Mediamaker Members can write a blogpost right from the frontend and have it publish to their own Channel on their profile as well as be visible on their social media feed. Try it, it’s simple. Signup or Login required.

Seven Years Facing a Wall

It’s been a huge learning process for me every step of the way, because the general trend in the world of psychedelic medicine is towards the clinical pathway, which is built on future fumes and has claimed millions of dollars and attention. Meanwhile, one person is dying every 10 minutes or so of overdose, and it costs a mere $10,000 to save that person’s life and a pathway exists NOW, outside the US to interrupt addiction with ibogaine. I feel that we as a society have become numb to the tragedy inherent in these numbers: More people have died of overdose than in many wars. Just today If one hundred people gave one hundred dollars we could save a life. Many people might spend that much several times a week on a meal.

Responses

Your email address will not be published. Required fields are marked *

×